Cargando…

Quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy

Background: Fluorescence angiography (FA) assesses anastomotic perfusion during esophagectomy with gastric conduit reconstruction, but its interpretation is subjective. This study evaluated time to fluorescent enhancement in the gastric conduit, with the aim to determine a threshold to predict posto...

Descripción completa

Detalles Bibliográficos
Autores principales: Slooter, M D, de Bruin, D M, Eshuis, W J, Veelo, D P, van Dieren, S, Gisbertz, S S, van Berge Henegouwen, M I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141822/
https://www.ncbi.nlm.nih.gov/pubmed/33016305
http://dx.doi.org/10.1093/dote/doaa100
_version_ 1783696447718293504
author Slooter, M D
de Bruin, D M
Eshuis, W J
Veelo, D P
van Dieren, S
Gisbertz, S S
van Berge Henegouwen, M I
author_facet Slooter, M D
de Bruin, D M
Eshuis, W J
Veelo, D P
van Dieren, S
Gisbertz, S S
van Berge Henegouwen, M I
author_sort Slooter, M D
collection PubMed
description Background: Fluorescence angiography (FA) assesses anastomotic perfusion during esophagectomy with gastric conduit reconstruction, but its interpretation is subjective. This study evaluated time to fluorescent enhancement in the gastric conduit, with the aim to determine a threshold to predict postoperative anastomotic complications. Methods: In a prospective cohort study, all consecutive patients undergoing esophagectomy with gastric conduit reconstruction from July 2018 to October 2019 were included. FA was performed before anastomotic reconstruction following injection of indocyanine green (ICG). During FA, the following time points were recorded: ICG injection, first fluorescent enhancement in the lung, at the base of the gastric conduit, at the planned anastomotic site, and at ICG watershed or in the tip of the gastric conduit. Anastomotic complications including anastomotic leakage and clinically relevant strictures were documented. Results: Eighty-four patients were included, the majority (67 out of 84, 80%) of which underwent an Ivor Lewis procedure. After a median follow-up of 297 days, anastomotic leakage was observed in 12 out of 84 (14.3%) and anastomotic stricture in 12 out of 82 (14.6%). Time between ICG injection and enhancement in the tip was predictive for anastomotic leakage (P = 0.174, area under the curve = 0.731), and a cut-off value of 98 seconds was derived (specificity: 98%). All times to enhancement at the planned anastomotic site and ICG watershed were significantly predictive for the occurrence of a stricture, however area under the curves were <0.7. Conclusions: The identified fluorescent threshold can be used for intraoperative decision making or to identify potentially high-risk patients for anastomotic leakage after esophagectomy with gastric conduit reconstruction.
format Online
Article
Text
id pubmed-8141822
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-81418222021-05-27 Quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy Slooter, M D de Bruin, D M Eshuis, W J Veelo, D P van Dieren, S Gisbertz, S S van Berge Henegouwen, M I Dis Esophagus Original Article Background: Fluorescence angiography (FA) assesses anastomotic perfusion during esophagectomy with gastric conduit reconstruction, but its interpretation is subjective. This study evaluated time to fluorescent enhancement in the gastric conduit, with the aim to determine a threshold to predict postoperative anastomotic complications. Methods: In a prospective cohort study, all consecutive patients undergoing esophagectomy with gastric conduit reconstruction from July 2018 to October 2019 were included. FA was performed before anastomotic reconstruction following injection of indocyanine green (ICG). During FA, the following time points were recorded: ICG injection, first fluorescent enhancement in the lung, at the base of the gastric conduit, at the planned anastomotic site, and at ICG watershed or in the tip of the gastric conduit. Anastomotic complications including anastomotic leakage and clinically relevant strictures were documented. Results: Eighty-four patients were included, the majority (67 out of 84, 80%) of which underwent an Ivor Lewis procedure. After a median follow-up of 297 days, anastomotic leakage was observed in 12 out of 84 (14.3%) and anastomotic stricture in 12 out of 82 (14.6%). Time between ICG injection and enhancement in the tip was predictive for anastomotic leakage (P = 0.174, area under the curve = 0.731), and a cut-off value of 98 seconds was derived (specificity: 98%). All times to enhancement at the planned anastomotic site and ICG watershed were significantly predictive for the occurrence of a stricture, however area under the curves were <0.7. Conclusions: The identified fluorescent threshold can be used for intraoperative decision making or to identify potentially high-risk patients for anastomotic leakage after esophagectomy with gastric conduit reconstruction. Oxford University Press 2020-10-03 /pmc/articles/PMC8141822/ /pubmed/33016305 http://dx.doi.org/10.1093/dote/doaa100 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Slooter, M D
de Bruin, D M
Eshuis, W J
Veelo, D P
van Dieren, S
Gisbertz, S S
van Berge Henegouwen, M I
Quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy
title Quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy
title_full Quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy
title_fullStr Quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy
title_full_unstemmed Quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy
title_short Quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy
title_sort quantitative fluorescence-guided perfusion assessment of the gastric conduit to predict anastomotic complications after esophagectomy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141822/
https://www.ncbi.nlm.nih.gov/pubmed/33016305
http://dx.doi.org/10.1093/dote/doaa100
work_keys_str_mv AT slootermd quantitativefluorescenceguidedperfusionassessmentofthegastricconduittopredictanastomoticcomplicationsafteresophagectomy
AT debruindm quantitativefluorescenceguidedperfusionassessmentofthegastricconduittopredictanastomoticcomplicationsafteresophagectomy
AT eshuiswj quantitativefluorescenceguidedperfusionassessmentofthegastricconduittopredictanastomoticcomplicationsafteresophagectomy
AT veelodp quantitativefluorescenceguidedperfusionassessmentofthegastricconduittopredictanastomoticcomplicationsafteresophagectomy
AT vandierens quantitativefluorescenceguidedperfusionassessmentofthegastricconduittopredictanastomoticcomplicationsafteresophagectomy
AT gisbertzss quantitativefluorescenceguidedperfusionassessmentofthegastricconduittopredictanastomoticcomplicationsafteresophagectomy
AT vanbergehenegouwenmi quantitativefluorescenceguidedperfusionassessmentofthegastricconduittopredictanastomoticcomplicationsafteresophagectomy